Watchlist Price Alert

Daré Bioscience Inc. (DARE)

NASDAQ: DARE · Real-Time Price · USD

2.83

-0.09 (-3.08%)

At close: Jun 20, 2025, 3:59 PM

2.77

-1.95%

After-hours: Jun 20, 2025, 04:43 PM EDT

-3.08% (1D)

Bid	2.77
Market Cap	25M
Revenue (ttm)	9.8M
Net Income (ttm)	-1.68M
EPS (ttm)	-0.17
PE Ratio (ttm)	-16.62
Forward PE	-3.01
Analyst	Buy

Ask	3.04
Volume	71,088
Avg. Volume (20D)	20,188
Open	2.95
Previous Close	2.92
Day's Range	2.75 - 2.95
52-Week Range	2.67 - 5.76
Beta	1.21

About DARE

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DARE

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DARE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Daré Bioscience Inc. is scheduled to release its earnings on Aug 11, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

10 months ago

+20%

Dare Bioscience shares are trading higher after th... Unlock content with Pro Subscription

10 months ago

+3.24%

Dare Bioscience shares are trading higher. The company reported Q2 financial results.

News

1 month ago · seekingalpha.com

Daré Bioscience, Inc. (DARE) Q1 2025 Earnings Call Transcript

Daré Bioscience, Inc. (NASDAQ:DARE ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants MarDee Haring-Layton - Chief Accounting Officer Sabrina Martucci Johnson - President ...

1 month ago · zacks.com

Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates

Dare Bioscience, Inc. (DARE) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.84 per share a year ago.

2 months ago · seekingalpha.com

Daré Bioscience, Inc. (DARE) Q4 2024 Earnings Call Transcript

Daré Bioscience, Inc. (NASDAQ:DARE ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants MarDee Haring-Layton - Chief Accounting Officer Sabrina Martucci Johnson - Presiden...

2 months ago · zacks.com

Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates

Dare Bioscience, Inc. (DARE) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to loss of $0.72 per share a year ago.